FAQ: Frequently Asked Questions
Nozin® Nasal Sanitizer® Advanced Antiseptic is a non-prescription product with demonstrated microbial killing activity that is topically applied with a swab to the skin at the opening (vestibule) of each nostril. The result of years of research, the patented Nasal Sanitizer® Nozaseptin™ formula combines the safe, proven, antiseptic power of ethyl alcohol with the emollient, antioxidant benefits of natural oils. Nozin Nasal Sanitizer® is well tolerated as it has a pleasant citrus scent, is gentle and highly moisturizing to the nasal opening, while maintaining potent antimicrobial activity. Unlike an antibiotic, Nasal Sanitizer® does not promote antibiotic resistance as it utilizes non-selective antiseptic action of ethanol.
This product is applied to the nasal vestibule, a critical site where pathogens, such as S. aureus, colonize. (see Learn About Staph aureus) After colonization pathogens can be transmitted, often by hand to nose contact, to others or to the skin where they can cause infections. Decolonization with Nozin Nasal Sanitizer® decreases nasal bacteria carriage, helps maintain hand hygiene by lowering chance of nose to hand transmission and can help reduce the risk of infections.
In testing by independent FDA registered laboratories, Nasal Sanitizer® was shown on application in vitro to kill 99.99% of a broad spectrum of pathogenic organisms. Nozin Nasal Sanitizer® has also been shown to decrease Staph aureus and other nasal bacteria carriage. To learn more product information, ingredients and how to apply with the POPswab® ampule click here.
Yes. Nozin Nasal Sanitizer® is well tolerated as it has a pleasant citrus scent and is highly moisturizing to the skin at the nasal opening, while maintaining potent antimicrobial activity. The product complies with Food and Drug Administration regulations for over the counter (OTC) drugs as an antiseptic. Ethanol, the active ingredient in Nasal Sanitizer®, is classified as GRASE (generally recognized as safe and effective) when used as directed. It has been shown that alcohol based topical antiseptics can be less irritating than soap and water* and Nasal Sanitizer® has been specifically shown to be safe in dermal toxicity and skin irritation studies.
Unlike an antibiotic, the Nasal Sanitizer® preparation does not promote antibiotic resistance as it utilizes the non-selective antiseptic action of ethanol. Nasal Sanitizer® is used and recommended by many health professionals and their patients. Read the entire package prior to use.
Nozin Nasal Sanitizer® can be used throughout your healthcare facility and hospital as an integral part of infection control to reduce nasal carriage, enhance hand hygiene efforts and lower the risk of nasal pathogen transmission. A comprehensive implementation could include:
- high risk areas such as Emergency Room and ICU
- pre and post procedure measures
- high risk areas such as Emergency Room and ICU
- facility/high risk areas
Learn about the 360™ Program and solutions for your facility.
Yes. The American Journal of Infection Control (AJIC) has published the article: “Reduction of nasal Staphylococcus aureus carriage in health care professionals by treatment with a nonantibiotic, alcohol-based nasal antiseptic”
Here's a link to AJIC website for the article on the clinical study which showed that Nozin® Nasal Sanitizer® antiseptic was effective in reducing Staph aureus and total bacterial carriage, ”suggesting the usefulness of this approach as a safe, effective and convenient alternative to antibiotic treatment.”
Yes. Nasal decolonization is an important topic which is covered in the whitepaper "Emerging Strategies on Achieving Nasal Decolonization for Reducing Hospital Acquired Infections". Studies show that nasal carriage plays a major role in HAI and SSI and that hygiene protocols which include nasal decolonization reduced infections by 40%. Nasal decolonization is a promising opportunity for infection control and remains under-utilized. Hand to nose contact occurs about every 4 minutes for everyone, often compromising hand hygiene and risking contamination. 80% of SSI pathogens’ DNA can be tracked to the patient’s own nose.
On the basis of new reimbursement policies and significant recent studies, facilities and hospitals recognize the imperative of patient nasal carriage reduction programs such as Universal Decontamination (HCA Hospitals), pre-operative screen and treat, and mupirocin use prior to surgery. Research also indicates that including nasal hygiene for health care workers (HCW) can also be beneficial. For more information see "Why You Need Nasal Sanitizer".
The Medical University of South Carolina initiated a clinical study that incorporated Nozin Nasal Sanitizer (see link at clinicaltrials.gov). The study is now complete and the results are published in the American Journal of Infection Control.
A number of factors support Nozin Nasal Sanitizer® use by HCWs. Studies show that 30% of the population has Staph aureus colonization in the nares. Chances are good that your facility’s HCWs have Staph colonization at that percentage. In addition, transient nasal inoculation by Staph aureus or other potential pathogens may occur through contact during the work day. All of these bacteria are then positioned for transfer to patients and other personnel. High risk areas like the ICU, ER and surgical floors would be recommended targets for the use of Nasal Sanitizer® to help reduce risk of infection.
As nose touching frequently compromises hand hygiene, Nasal Sanitizer® can be used to complement hand washing and hand sanitizer use. HCWs can regularly use Nasal Sanitizer® antiseptic (recommended 2-3 times per 12 hour shift) as it gives them an extra layer of protection in addition to hand hygiene. The application is pleasant, moisturizing and, importantly, bacteria will not build antibiotic resistance to this non-antibiotic product. For more information see "Why You Need Nasal Sanitizer®". Also of interest are comments of Dr. Roque on adoption of Nozin Nasal Sanitizer at Riviera Health Resort.
As stated above, studies show that ~30% of the population has Staph aureus colonization in the nares and ~3% have MRSA. Providing patients upon admission with Nozin Nasal Sanitizer® can help reduce the risk of bringing these potential pathogens into the healthcare facility.
The Nozin Team will fully support facilities as they go through the implementation process and assist in creating high-impact clinical protocols for Nasal Sanitizer®.
Learn about the Nozin Shield™ Program and solutions for your facility.
Nozin Nasal Sanitizer® comes in convenient single use POPswab® ampulesin various bulk configurations and dispensers. The product is also available in a multi-use 12ml bottle with cotton swabs. You can read more about product information here. For a review of specific options best suited for your facility contact a Nozin representative.
Yes. Nozin® Nasal Sanitizer® is a latex-free product.
For less than the cost of screening alone, you can effectively implement a decolonization program using Nozin® Nasal Sanitizer®. Contact your Nozin representative to review options for your facility.
Global Life Technologies Corp. is the maker of Nozin® brand products including Nasal Sanitizer® and Allergy Master®. Located in Chevy Chase, MD, this U.S. based company follows a mission to improve the quality of life for people by introducing unique and effective healthcare products based on innovative patented and patent pending technologies. Backed by nine years of research, supported by NIH grants and successful clinical trials, Nozin products are directed at growing health maintenance and disease prevention markets. Made in the USA, Nozin products have been well received by doctors and healthcare professionals who use them and recommend them to patients.
- In lab tests Nozin Nasal Sanitizer® killed 99.99% of germs.
- Only high-grade ingredients are used.
- Clinically proven. Read up on the research here.
- Nasal Sanitizer® is long-acting, effective and available without a prescription.